Quick Answer
Aura Biosciences, Inc. reported Shares Outstanding of 63.59 million shares for fiscal year 2025.
Aura Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 63.59M | +27.2% |
| 2024 | 50.00M | +1.3% |
| 2023 | 49.35M | +30.7% |
| 2022 | 37.77M | +29.3% |
| 2021 | 29.21M | +7564.6% |
| 2020 | 381,123 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 62.99M | +26.5% | +1.5% |
| June 30, 2025 | 62.07M | +25.2% | +23.6% |
| March 31, 2025 | 50.23M | +1.5% | +0.5% |
| December 31, 2024 | 50.00M | +1.3% | +0.4% |
| September 30, 2024 | 49.78M | +30.3% | +0.4% |
| June 30, 2024 | 49.58M | +30.2% | +0.2% |
| March 31, 2024 | 49.50M | +31.0% | +0.3% |
| December 31, 2023 | 49.35M | +30.7% | +29.1% |
- Aura Biosciences, Inc. showed an increase of +27.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Aura Biosciences, Inc.’s shares outstanding has grown by 16584.3% (from 381.1 thousand shares to 63.59 million shares).
- The most recent figure is from Aura Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: